Indications and uses
May temporarily relieve symptoms associated with the flu, such as aches and pains.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
DRUG FACTS:
- Manufacturer
- Energique, Inc. | Apotheca Company
- Effective date
- 2026-04-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:38:20
Label at a glance#
ProductInfluenzinum 200C
Active ingredientINFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)
Label structure9 sections
Dosage and administration
Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 3 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENT:
(in each drop) 100% of Influenzinum 200C.
PURPOSE:
May temporarily relieve symptoms associated with the flu, such as aches and pains.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
WARNINGS:
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
KEEP OUT OF REACH OF CHILDREN:
In case of overdose, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional.
If symptoms persist for more than 3 days, consult your health care professional.
Consult a physician for use in children under 12 years of age.
USES:
May temporarily relieve symptoms associated with the flu, such as aches and pains.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INACTIVE INGREDIENTS:
Demineralized water, 20% Ethanol.
QUESTIONS:
Dist. by Energique, Inc.
201 Apple Blvd.
Woodbine, IA 51579
800.869.8078
PACKAGE LABEL DISPLAY:
ENERGIQUE
SINCE 1987
HOMEOPATHIC REMEDY
INFLUENZINUM 200C
2025-2026
1 fl. oz. (30 ml)
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0363113600056 | GTIN-13: 0363113600056 EAN-13: 0363113600056 GTIN-12: 363113600056 UPC-A: 363113600056 GTIN storage (14 digits): 00363113600056 | ENRG0898 Influenzinum 200C 11-24-25.jpg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44911-0905-1 | Influenzinum 200C | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | 1 |
Products#
Every source-derived product name is available through these pages.
- Influenzinum 200C
- Influenzinum (2025-2026)
- INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)
- INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 44911-0905 | 44911-0905-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Influenzinum 200C | INFLUENZINUM (2025-2026) | Energique, Inc. | 4e4c7efe-c133-4f12-a10e-2fa111fac584 | 2026-04-15 | Warnings | 44911-0905-1 44911-0905 44911090501 7d7554b1-6f99-46b9-9be4-c6054577087f 4e4c7efe-c133-4f12-a10e-2fa111fac584 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.